AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
BUSINESS BRIEFS.(TO THE POINT)
MEDICAL
Amylin files for lizard spit drug
The drug maker and Eli Lilly asked U.S. regulators for permission to market a new treatment -- derived from the saliva of a desert lizard -- for Type 2 diabetes. The drug is the first in a new class of medicines known as incretin mimetics to treat the adult-onset diabetes, which affects about 15 mil Americans. Amylin rose 3% to 22.80.
Teva plans Warner case appeal
The world's No. 1 generic drug maker will appeal a U.S. court's decision to validate Pfizer subsidiary Warner-Lambert's patent for anti-hypertension drug Accupril. The drug, which made $589 mil in sales last year, is patented until '07. The FDA had given Teva's generic version Quinapril approval in '03 after a court granted the patent, and Warner-Lambert sued for infringement. Shares fell 1% to 67.18.
** Alnylam Pharmaceuticals and Merck have teamed up to develop and commercialize therapies for eye diseases. Alnylam shares rose 6.5% to 7.56.
** Biosite received a green light from ...
- Trade Alert for Bristol-Myers Squibb Co.
- Press release article from: M2 Presswire January 29, 2007 700+ words
...date information on Bristol-Myers Squibb Co are invited to sign up for...credit card needed! Bristol-Myers Squibb Co. shares rose nearly 8 percent Monday after...comment. Shares of Bristol-Myers Squibb traded in Frankfurt jumped...
- Bristol-Myers Squibb ousts CEO Dolan.
- News wire article from: Europe Intelligence Wire September 12, 2006 700+ words
...Europe (Focus)) NEW YORK (AFX) - Bristol-Myers Squibb Co. on Tuesday ousted Peter R. Dolan as chief...board member and former general counsel. Bristol-Myers Squibb shares rose 62 cents, or 2.7 percent, to $24.01 in midday...
- Bristol-Myers Squibb ousts CEO Dolan, General Counsel Willard.
- News wire article from: The America's Intelligence Wire September 12, 2006 700+ words
...Worldstream) Byline: WALLACE WITKOWSKI Bristol-Myers Squibb Co. on Tuesday ousted Peter R. Dolan as chief...board member and former general counsel. Bristol-Myers Squibb shares rose $1.08, or 4.6 percent, to $24.47 in early...
- Bristol-Myers Squibb ousts CEO Dolan, General Counsel Willard at urging of...
- News wire article from: The America's Intelligence Wire September 12, 2006 700+ words
...Worldstream) Byline: WALLACE WITKOWSKI Bristol-Myers Squibb Co. on Tuesday ousted Peter R. Dolan as chief...board member and former general counsel. Bristol-Myers Squibb shares rose 62 cents, or 2.7 percent, to $24.01 in midday...
- Speculation of Sanofi-Aventis buyout sends Bristol-Myers Squibb shares soaring.
- News wire article from: The America's Intelligence Wire January 29, 2007 700+ words
...STEPHANIE REITZ Bristol-Myers Squibb Co. shares rose nearly 8 percent Monday after...comment. Shares of Bristol-Myers Squibb traded in Frankfurt jumped...grow organically. Bristol-Myers Squibb reported a loss of US$134...
- Current Research on Bristol-Myers Squibb Co.
- Press release article from: M2 Presswire January 31, 2007 700+ words
...customer for Bristol-Myers Squibb (BMS). The pharmaceutical...information on Bristol-Myers Squibb Co are invited to sign...Shares of Bristol-Myers Squibb Co. climbed Wednesday...handle buyout attempts. Shares rose to a new 52-week high...
- Shareholders alert for Bristol-Myers Squibb Co.
- Press release article from: M2 Presswire June 19, 2007 700+ words
...News: Shareholders alert for Bristol-Myers Squibb Co(C)1994-2007 M2 COMMUNICATIONS LTD...19062007 Shareholders alert for Bristol-Myers Squibb Co (NYSE:BMY) Bristol-Myers Squibb Company (BMS) engages in the discovery...
- Bristol-Myers Squibb Co Patent Valid.
- Press release article from: M2 Presswire June 20, 2007 700+ words
...HEADLINES: Bristol-Myers Squibb Co Patent Valid(C...shareholder of Bristol-Myers Squibb Co (NYSE:BMY...victory to Bristol-Myers Squibb Co. and Sanofi-Aventis...Tabak. Bristol-Myers shares rose $1.42, or 4.68...
- 45-Year-Old CEO of Bristol-Myers Squibb Says Age Isn't an Issue.
- Newspaper article from: Knight Ridder/Tribune Business News February 8, 2001 700+ words
...few years ago to head Bristol-Myers Squibb's nutritional business, a contractor...named chief executive at Bristol-Myers Squibb, which has its pharmaceutical...knees business." Yesterday, shares rose $1.43, or 2.3 percent...
- Schaeffer's Street Chatter Highlights the Following Stocks: Bristol-Myers...
- Press release article from: Business Wire October 29, 2004 700+ words
...Research focuses on: Bristol-Myers Squibb (NYSE:BMY), Halliburton...Pharmaceutical name Bristol-Myers Squibb (NYSE: BMY) stepped into the...Meanwhile the number of shorted HAL shares rose almost 10 percent last month to...
